OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 10:00
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
Playmaker Capital Inc. Named Sports Media Company of the Year by SBC
Qualcomm, Google partner to make RISC-V chip for wearable devices
Criminal Marketplaces Provide Gateway to Rising Account Fraud and Identity Theft
QuSecure Expands its Board of Directors with Cisco Distinguished Engineer
Apple, Meta Hot Streaks Fuel Nasdaq 100’s July Rally
The MIRA Surgical System Proceeds to FDA Substantive Review for Market Authorization Under the De Novo Classification Pathway
UK Has Hottest Day of the Year as September Heat Tops Record
Google hires Brazil's Temer to lobby on controversial internet bill